Chapter 4: Hemodynamic Disorders, Thromboembolic Disease, and Shock

A central focus is normal hemostasis, detailing the highly orchestrated interactions between the vascular endothelium, primary platelet plug formation—facilitated by von Willebrand factor and specific glycoprotein receptors—and the secondary coagulation cascade, which culminates in thrombin generation and insoluble fibrin deposition. The chapter contrasts this physiological process with pathological hemorrhagic disorders and thrombosis, extensively analyzing the Virchow triad of endothelial injury, abnormal blood flow including stasis and turbulence, and primary or secondary hypercoagulability. This includes an analysis of inherited conditions like Factor V Leiden and acquired states such as heparin-induced thrombocytopenia and antiphospholipid antibody syndrome. The progressive fate of thrombi is explored, leading directly into the mechanisms of embolism, encompassing pulmonary emboli originating from deep vein thromboses, systemic thromboembolism, fat, air, and amniotic fluid emboli. Furthermore, the text examines how these vascular occlusions result in red hemorrhagic or white anemic tissue infarctions based on dual versus end-arterial vascular anatomy and intrinsic tissue vulnerability to hypoxia. Finally, the chapter provides a comprehensive breakdown of shock—specifically cardiogenic, hypovolemic, and septic shock—highlighting the devastating systemic inflammatory response triggered by pathogen-associated molecular patterns, subsequent metabolic derangements, profound endothelial dysfunction, and disseminated intravascular coagulation that collectively characterize end-stage multiorgan failure as the condition progresses from initial nonprogressive compensatory phases to irreversible cellular injury.